Effects of dexfenfluramine on serotonin levels of mice ileum, contractility, glutathione and malondialdehyde level.
Dexfenfluramine is one of the anorectic drugs that suppresses food intake which acts via inhibition of reuptake of serotonin into brain terminal. Gastrointestinal tract is the main source of peripheral serotonin which is involved in the regulation of gastrointestinal motility. During the use of anorectic drugs, the antioxidant defence is affected especially by reactive oxygen species. The purpose of this study to search: The effect of dexfenfluramine on serotonin levels of ileum and the effect of dexfenfluramine on ileal contractility and oxidative stress.


METHODS
Twenty-two adult male Swiss-albino mice were divided two groups (1) Control, (2) Dexfenfluramine treated (i.p. twice a day 0.2 mg kg(-1) in 0.2 ml saline solution for 7 days). Animal body weights were recorded at the beginning and at the end of the experimental period. Ileum tissues contractile responses to different concentrations of KCl and acethycholine were recorded on polygraph. In the meantime ileal tissue malondialdehyde, a product of lipid peroxidation, and glutathione, endogenous antioxidant levels were assessed by spectrophotometric methods. Ileal tissue serotonin level determined by immunohistochemical method. Body weights decrease and ileal contractile response of acethycholine increased significantly by dexfenfluramine treatment. Meanwhile, ileum glutathione levels decreased and malondialdehyde levels increased in dexfenfluramine treated group. Immunohistochemical detection showed that ileal serotonin levels increased by dexfenfluramine treatments. As a conclusion, there is a relationship between increased ileal contractility and oxidant status in dexfenfluramine treated animals. These effects can be related by increased serotonin levels which is induced by dexfenfluramine in ileum.
Ozer
Ciüdem
C
Faculty of Medicine, Department of Physiology, University of Gazi, Ankara, Turkey. ozercigdem@yahoo.co.uk
Gönül
Bilge
B
Elmas
Ciüdem
C
Erdoüan
Deniz
D
Ercan
Z Sevim
ZS
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D035061:Control Groups; D020372:Dexfenfluramine / Q000494:pharmacology*; D005247:Feeding Behavior / Q000187:drug effects; D005978:Glutathione / Q000378:metabolism*; D007082:Ileum / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology; D008315:Malondialdehyde / Q000378:metabolism*; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D010084:Oxidation-Reduction; D012701:Serotonin / Q000378:metabolism*
D012701:Serotonin; D008315:Malondialdehyde; D020372:Dexfenfluramine; D005978:Glutathione